Casma Therapeutics website screenshot

Casma Therapeutics

Casma Therapeutics is a privately held clinical-stage biotechnology company founded in 2018 and headquartered at 201 Brookline Ave, Suite 1401, Boston, MA. Casma develops novel cellular degradation medicines built on the autophagy pathway — the conserved process cells use to clear damaged components. Its PHLYT (Phagosome-Lysosome Targeting) platform initiates target-specific autophagic degradation of disease targets independent of size or complexity, reaching beyond single proteins to organelles, protein aggregates and large signaling complexes, with programs spanning oncology, inflammation, neurodegeneration and metabolic disease. Casma was named to the Fierce 15 list in 2019. The company publishes no public developer API, developer portal, SDKs or machine-readable API contract; it is catalogued here as a company profile only.

Casma Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Drug Discovery.

Casma Therapeutics’ developer surface includes engineering blog and 14 more developer resources.

10.3/100 minimal ▬ flat Agent 0/100 human only saas Full breakdown ↓
scored 2026-09-14 · rubric v0.22.0
0 APIs
CompanyBiotechnologyPharmaceuticalsLife SciencesDrug DiscoveryTherapeuticsAutophagyHealth

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-14 · rubric v0.22.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/casma-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Casma Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 6

The organization behind the API

Other 4

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: casma-therapeutics
name: Casma Therapeutics
description: Casma Therapeutics is a privately held clinical-stage biotechnology company founded in 2018 and headquartered
  at 201 Brookline Ave, Suite 1401, Boston, MA. Casma develops novel cellular degradation medicines built on the autophagy
  pathway — the conserved process cells use to clear damaged components. Its PHLYT (Phagosome-Lysosome Targeting) platform
  initiates target-specific autophagic degradation of disease targets independent of size or complexity, reaching beyond single
  proteins to organelles, protein aggregates and large signaling complexes, with programs spanning oncology, inflammation,
  neurodegeneration and metabolic disease. Casma was named to the Fierce 15 list in 2019. The company publishes no public
  developer API, developer portal, SDKs or machine-readable API contract; it is catalogued here as a company profile only.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://www.casmatx.com/wp-content/themes/casma/images/brand-logo.svg
url: https://raw.githubusercontent.com/api-evangelist/casma-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-02'
modified: '2026-08-02'
x-enrichment:
  date: '2026-08-02'
  status: minimal
  artifacts_added: 3
  pass: local-v1
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Drug Discovery
- Therapeutics
- Autophagy
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/casma-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/casma-therapeutics-llms.txt
- type: Website
  url: https://www.casmatx.com/
- type: About
  url: https://www.casmatx.com/about/
- type: Contact
  url: https://www.casmatx.com/contact-us/
- type: Blog
  url: https://www.casmatx.com/news-media/
- type: PrivacyPolicy
  url: https://www.casmatx.com/privacy-policy/
- type: TermsOfService
  url: https://www.casmatx.com/terms-of-use/
- type: Careers
  url: https://www.casmatx.com/careers-culture/
- type: Investors
  url: https://www.casmatx.com/investors/
- type: Team
  url: https://www.casmatx.com/our-team/
- type: Science
  url: https://www.casmatx.com/science/
- type: Pipeline
  url: https://www.casmatx.com/platform-pipeline/
- type: LinkedIn
  url: https://www.linkedin.com/company/casma-tx
- type: SecondaryMarket
  url: https://forgeglobal.com/casma-therapeutics_stock/

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/casma-therapeutics"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/casma-therapeutics/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/casma-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.